Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > A comparative immunohistochemical analysis of COX-2, p53, and Ki-67 expression in keratocystic odontogenic tumors
Publication

Publications

A comparative immunohistochemical analysis of COX-2, p53, and Ki-67 expression in keratocystic odontogenic tumors

Title
A comparative immunohistochemical analysis of COX-2, p53, and Ki-67 expression in keratocystic odontogenic tumors
Type
Article in International Scientific Journal
Year
2011
Authors
Carvalho, JFC
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
van der Waal, I
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 111
Pages: 333-339
ISSN: 1079-2104
Publisher: Mosby - Elsevier
Other information
Authenticus ID: P-002-TVP
Abstract (EN): Objective. The aim of the present study was to investigate the association between the expression of cyclooxygenase-2 (COX-2) in keratocystic odontogenic tumors (KCOT) and more commonly used markers, such as p53 and Ki-67. Study design. Expression of cyclooxygenase-2 (COX-2) in 20 biopsy specimens of keratocystic odontogenic tumors (KCOT) has been analyzed and compared with the expression of previously reported markers Ki-67 and p53. Formalin-fixed, paraffin-embedded blocks were sectioned and used for hematoxylin-eosin (H&E) staining and incubated with anti-cox-2, anti-ki-67, and anti-p53 monoclonal antibodies for immunohistochemical examination. Detection of the COX-2 antibody was performed with the EnVision kit. Cellular staining pattern was cytoplasmatic for COX-2 and nuclear for both Ki-67 and p-53. Molecular expressions were semiquantitatively evaluated as negative (-), mild (+/-) or strong (+). Results. Mild to strong expression of COX-2 was observed in 20 (100%) of the cases. Fifteen (75%) of the KCOTs stained positive for p53 and 18 (90%) stained positive for Ki-67. There was no statistically relevant difference between the expressions of COX - 2, Ki-67, and p53. Conclusions. Although COX-2 has rarely been used to assess the biological activity of the KCOT, the results portrayed in the current study and the current knowledge of the overall role known to be played by COX-2 in tumorigenesis suggest that COX-2 may be an important marker involved in the biological behavior of the KCOT. Larger studies are required to improve our knowledge of the possible role of COX-2 in the pathogenic mechanism involved in KCOT. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;111:333-339)
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 7
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Characterization and management of the keratocystic odontogenic tumor in relation to its histopathological and biological features (2010)
Another Publication in an International Scientific Journal
Mendes, RA; Carvalho, JFC; van der Waal, I
An overview on the expression of cyclooxygenase-2 in tumors of the head and neck (2009)
Another Publication in an International Scientific Journal
Mendes, RA; Carvalho, JFC; van der Waal, I
The aggressive behaviour of the keratocystic odontogenic tumor - New biological insights (2009)
Other Publications
Mendes, RA; Nogueira, R; Carvalho, JFC; van der Waal, I
Potential relevance of cyclooxygenase-2 expression in keratocystic odontogenic tumours - an immunohistochemical study (2011)
Article in International Scientific Journal
Mendes, RA; Carvalho, JFC; van der Waal, I

Of the same journal

Oral squamous cell carcinoma: Review of prognostic and predictive factors (2006)
Article in International Scientific Journal
João Massano; Regateiro, FS; Januario, G; Ferreira, A
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-08 at 03:46:47 | Privacy Policy | Personal Data Protection Policy | Whistleblowing